Fernwood Investment Management’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Fernwood Investment Management’s Portfolio FOMX Stock Details FOMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-34,000	Closed	–	–	172
2020 Q1	$0	Hold	34,000	–	–	﹤0.01%	169
2019 Q4	$113K	Hold	34,000	–	–	0.05%	153
2019 Q3	$103K	Hold	34,000	–	–	0.05%	176
2019 Q2	$81K	Hold	34,000	–	–	0.04%	149
2019 Q1	$128K	Hold	34,000	–	–	0.07%	152
2018 Q4	$122K	Sell	34,000 -20,000	-37%	-$87K	0.08%	141
2018 Q3	$309K	Buy	+54,000	New	+$309K	0.16%	127

Fernwood Investment Management's FOMX Position: Q2 2020 in Review

Fernwood Investment Management sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q2 2020, closing a stake of 34,000 shares.

Fernwood Investment Management first reported a position in FOMX in Q3 2018 and held it in 7 quarters. The position peaked at $309K in Q3 2018. 0 funds tracked by Wall St. Rank hold FOMX as of Q2 2020.

Fernwood Investment Management reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q2 2020 after selling out during the quarter.
Fernwood Investment Management sold 34,000 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q2 2020.
Fernwood Investment Management first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q3 2018 and held it in 7 quarters.
Fernwood Investment Management's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $309K in Q3 2018.
0 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q2 2020.

Based on Fernwood Investment Management's 13F filing for Q2 2020, filed 6 Aug 2020.